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The power of cooperation
Hugo M van der Kuy   
COVID-19 has changed the world 
rapidly in ways we would never have 
imagined at the end of 2019. This has 
been described already earlier in this 
journal.1 Research however appears to be 
blooming like weeds in spring. It comes 
from everywhere, grows everywhere and 
sometimes it becomes important and 
sometimes its destiny is an early death.
China faced the virus 2–3 months 
ahead of Europe, which might have 
given them a window of opportunity to 
set the example.
Unfortunately, most of the research 
published until now from the ‘COVID- 
china’ is relatively small, a single- arm 
with no control group, no randomisation 
and often from a single centre.
This is unfortunate as it has led to 
the treatment of thousands of people 
on assumptions that were not scientifi-
cally based as we normally require, for 
example, the treatment with chloroquine.
Overwhelmed by the number of 
patients admitted to the hospitals one 
of the most important tenets of medi-
cine was hampered: ‘primum no nocere’, 
first do no harm. Apart from the ther-
apeutic problems, the world has been 
faced with logistical challenges at a time 
when most logistical transport were 
shutting down. This has lead in several 
countries to shortages of essential ICU 
medicines. The response of some people 
is to become egoistic: first my hospital, 
then the area of our hospital followed by 
our country and then the rest of Europe 
and finally the rest of the world. This 
has led to a reaction of countries to close 
their borders for the export of certain 
medicines. Nine leading academic hospi-
tals from the EUHA (European Univer-
sity Hospitals Alliance) in Europe have 
published a letter to urge the European 
committee to take the lead and think 
Europe- wide instead of a self- serving 
reflex.2 It is however difficult to let 
rational thoughts of cooperation rise 
above animal instincts to get everything 
arranged right for yourself.
Back to the area of therapeutic 
research, I hope that the overwhelming 
amount of research that has started in 
several countries all over Europe does 
not lead to unfinished trials that are not 
sufficiently powered to solve key thera-
peutic questions. The future will tell us 
if we in Europe did better than China. In 
this journal a protocol article is published 
which describes an observational study 
across Europe. At the moment this Edito-
rial is written, no data are currently avail-
able. However, the study is supported by 
13 countries in Europe and more than 60 
hospitals.
Apart from any therapeutic outcomes, 
the enthusiastic reactions from all over 
Europe, by mail, LinkedIn or telephone 
have provided an energy boost that can 
be compared with winning an Olympic 
medal! It has strengthened my belief in 
the power of cooperation. Together we 
are strong.3
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